Braun-Bostich & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.62M | Sell |
6,374
-129
| -2% | -$30.1K | 0.9% | 32 |
|
|
2026
Q1 | $1.59M | Sell |
6,503
-472
| -7% | -$110K | 1% | 32 |
|
|
2025
Q4 | $1.44M | Sell |
6,975
-602
| -8% | -$119K | 0.89% | 32 |
|
|
2025
Q3 | $1.4M | Sell |
7,577
-2
| -0% | -$343 | 0.89% | 32 |
|
|
2025
Q2 | $1.16M | Buy |
7,579
+71
| +0.9% | +$10.9K | 0.79% | 36 |
|
|
2025
Q1 | $1.25M | Buy |
7,508
+25
| +0.3% | +$3.91K | 0.92% | 32 |
|
|
2024
Q4 | $1.08M | Sell |
7,483
-294
| -4% | -$45.6K | 0.78% | 34 |
|
|
2024
Q3 | $1.26M | Buy |
7,777
+483
| +7% | +$77K | 0.88% | 30 |
|
|
2024
Q2 | $1.07M | Buy |
7,294
+630
| +9% | +$93.7K | 0.79% | 33 |
|
|
2024
Q1 | $1.05M | Buy |
6,664
+317
| +5% | +$50.5K | 0.88% | 31 |
|
|
2023
Q4 | $995K | Buy |
6,347
+4,861
| +327% | +$745K | 0.9% | 25 |
|
|
2023
Q3 | $231K | Sell |
1,486
-3,309
| -69% | -$546K | 0.43% | 46 |
|
|
2023
Q2 | $794K | Buy |
4,795
+328
| +7% | +$52.9K | 1.7% | 19 |
|
|
2023
Q1 | $692K | Buy |
4,467
+477
| +12% | +$77K | 1.64% | 23 |
|
|
2022
Q4 | $705K | Buy |
3,990
+172
| +5% | +$29.7K | 2.03% | 20 |
|
|
2022
Q3 | $624K | Buy |
3,818
+80
| +2% | +$13.5K | 1.91% | 23 |
|
|
2022
Q2 | $664K | Buy |
3,738
+113
| +3% | +$20.1K | 1.73% | 25 |
|
|
2022
Q1 | $642K | Buy |
3,625
+2,276
| +169% | +$387K | 1.38% | 23 |
|
|
2021
Q4 | $226K | Sell |
1,349
-1,864
| -58% | -$305K | 0.05% | 99 |
|
|
2021
Q3 | $519K | Hold |
3,213
| – | – | 0.98% | 29 |
|
|
2021
Q2 | $529K | Sell |
3,213
-70
| -2% | -$11.6K | 0.96% | 27 |
|
|
2021
Q1 | $540K | Sell |
3,283
-35
| -1% | -$5.66K | 1.04% | 26 |
|
|
2020
Q4 | $522K | Sell |
3,318
-3,617
| -52% | -$534K | 1.05% | 29 |
|
|
2020
Q3 | $1.03M | Sell |
6,935
-3,480
| -33% | -$515K | 1.03% | 20 |
|
|
2020
Q2 | $1.47M | Buy |
10,415
+243
| +2% | +$35.4K | 1.43% | 12 |
|
|
2020
Q1 | $1.31M | Sell |
10,172
-377
| -4% | -$53.5K | 1.67% | 10 |
|
|
2019
Q4 | $1.54M | Sell |
10,549
-112
| -1% | -$15.2K | 1.52% | 13 |
|
|
2019
Q3 | $1.38M | Buy |
10,661
+387
| +4% | +$51K | 1.6% | 12 |
|
|
2019
Q2 | $1.43M | Sell |
10,274
-41
| -0.4% | -$5.67K | 1.5% | 12 |
|
|
2019
Q1 | $1.44M | Sell |
10,315
-1,869
| -15% | -$250K | 1.5% | 11 |
|
|
2018
Q4 | $1.57M | Sell |
12,184
-3,575
| -23% | -$499K | 1.67% | 14 |
|
|
2018
Q3 | $2.18M | Buy |
15,759
+22
| +0.1% | +$2.92K | 2.1% | 10 |
|
|
2018
Q2 | $1.91M | Buy |
15,737
+4,073
| +35% | +$508K | 1.91% | 9 |
|
|
2018
Q1 | $1.5M | Sell |
11,664
-1,397
| -11% | -$189K | 1.29% | 22 |
|
|
2017
Q4 | $1.82M | Buy |
+13,061
| New | +$1.82M | 1.55% | 16 |
|
Other funds holding JNJ
PAM
WT
CGI
Braun-Bostich & Associates's JNJ Position: Q2 2026 in Review
Braun-Bostich & Associates reduced its Johnson & Johnson (JNJ) stake by 2% in Q2 2026, selling an estimated $30.1K and leaving 6,374 shares worth $1.62M. The position accounts for 0.9% of the portfolio, ranked #32.
Braun-Bostich & Associates first reported a position in JNJ in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.18M in Q3 2018. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Braun-Bostich & Associates held 6,374 shares of Johnson & Johnson worth $1.62M as of Q2 2026.
- Braun-Bostich & Associates sold 129 Johnson & Johnson shares in Q2 2026, an estimated $30.1K.
- Johnson & Johnson made up 0.9% of Braun-Bostich & Associates's portfolio in Q2 2026, its #32 holding.
- Braun-Bostich & Associates first reported a position in Johnson & Johnson in Q4 2017 and has held it in 35 quarters since.
- Braun-Bostich & Associates's Johnson & Johnson position peaked at $2.18M in Q3 2018.
- 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Braun-Bostich & Associates's 13F filing for Q2 2026, filed 24 Jul 2026.